Brazil's first oncology biotech launches

(New York, June 14)--Recepta, Brazil's first oncology biotechnology company was launched today by PR&D, a Brazilian venture capital company, and the international non-profit Ludwig Institute for Cancer Research (LICR). The company will explore the therapeutic potential of three antibodies discovered and characterized by LICR.

One of the antibodies in Receptas portfolio is expected to enter clinical trials this year. Internal review board permission has been granted by So Paulos Oswaldo Cruz German Hospital (HAOC), one of the centers of clinical excellence in Brazil, to conduct a clinical trial assessing the antibodys efficacy for patients with resected ovarian cancer. This will be the first phase II oncology clinical trial sponsored by a Brazilian company. Recepta will conduct preclinical work with investigators at the So Paulo Branch of LICR, which is based at HAOC.

According to the director of Recepta, Dr. Jos Fernando Perez, the company has benefited greatly from the international collaborations and support provided by LICR. Its important to appreciate that the Ludwig Institute is more than simply a share-holder in Recepta. This is a partnership that involves Ludwig Institute investigators from around the world contributing their knowledge and expertise to assist Receptas development efforts. Dr. Perez, who is the former director of FAPESP (State of Sao Paulo funding body), says that the partnership between LICR and PR&D evolved from an institutional partnership formed by LICR and FAPESP in the 1990s. That partnership created the internationally acclaimed ONSA (Organization for Nucleotide Sequencing and Analysis) and Human Cancer Genome Project (HCGP), state- and nation-wide sequencing programs, respectively, that brought Brazilian genomics to the worlds attention.

LICR's senior scientific officer, Dr. Andrew Simpson, who was a key player in ONSA and HCGP, says that the development of Recepta re-emphasizes the Institutes belief i

Contact: Sarah L. White
Ludwig Institute for Cancer Research

Page: 1 2

Related biology news :

1. Report shows deforestation threatens Brazils Pantanal
2. Selective logging causes widespread destruction of Brazils Amazon rainforest, study finds
3. Saudi Arabias KAUST names WHOI first research partner
4. Which came first, the moth or the cactus?
5. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
6. Seawater intrusion is the first cause of contamination of coastal aquifers
7. Camera-shy deer caught for first time
8. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
9. New joint replacement material developed at MGH put to first clinical use
10. Liverpool amongst first in UK to install unique DNA sequencing technology
11. A first-principles model of early evolution

Post Your Comments:

(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint ... reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol ...
(Date:6/28/2020)... ... 25, 2020 , ... In an upcoming episode scheduled for the fall of ... Testing solutions (POCT). Check local listings for more info. , Today, the majority of ... shipped to labs throughout the country. Results are then available several days later. Now, ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... RIDING, Va. (PRWEB) , ... September 01, 2020 ... ... firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of ... . Averill will be responsible for leading all financial operations and implementing key ...
(Date:8/15/2020)... ... 13, 2020 , ... True Terpenes , the leading platform for terpene ... (SAB) to research the medical potential of terpenes and the potential entourage effect ... The board is focused on expanding the recently launched line of effects-based terpenes - ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society ... Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of ... a consortium of academic research centers in the United States and Europe with ...
(Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
Breaking Biology Technology:
Cached News: